TABLE 2.
The dimensions of HB-HTA investigated in the current paper (derived from refs 3 and 4).
| Dimension | Item |
|---|---|
| Clinical | • Safety/risk |
| • Efficacy/effectiveness | |
| • Mortality/survival rates | |
| • Population to be treated (donors, recipients) | |
| • Incidence/prevalence of illness | |
| Economic(al) | • Costs |
| • Cost-effectiveness, cost utility, cost opportunity | |
| • Resource(s) | |
| Ethical | • Patient acceptance/comfort |
| • Access to novel HT | |
| • Equity | |
| • Potential patient harm | |
| Social | • Patient quality of life |
| • Pain/discomfort | |
| • Time in hospital/patient burden | |
| Organizational | • Training |
| • Equipment availability/location | |
| • Resource constraints | |
| Human factors | • Acceptance/acceptability |
| • Usability/ease of use |
Note. HT, health technology; HB-HTA, hospital-based HTA; HTA, health technology assessment.